Among General Practices, does a simple promotion strategy to encourage practitioners to screen parents for history of MMR vaccination whilst they attend the practice to have their young children vaccinated, result in an increase in the number of adults vaccinated against MMR, compared to existing ad-hoc practices?
Status: Withdrawn prior to enrolment
Phase of Trial: Phase IV
Latest Information Update: 02 Jul 2019
Price : $35 *
At a glance
- Drugs Measles mumps and rubella virus vaccine-(Priorix) (Primary)
- Indications Measles; Mumps; Rubella
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline
- 04 Nov 2013 Status changed from not yet recruiting to withdrwan prior to enrollment as reported by Australian New Zealand Clinical Trials Registry.
- 20 Feb 2013 New trial record